Reporter April 26 2019

A new antibiotic’s mechanism of action

Vanderbilt investigators have characterized how a new first-in-class antibacterial drug works, which will guide the development of additional compounds that overcome antibacterial resistance.

Immune ‘pruning’ in schizophrenia

Ariel Deutch and colleagues have discovered that overactive brain immune cells during adolescence may contribute to schizophrenia.

Receptor’s role in stopping H. pylori

The immune receptor NOD1 may be a prime target for preventing or treating H. pylori infections — the most significant risk factor for stomach cancer, Vanderbilt researchers have discovered.

Low oxygen and antibody responses

Mark Boothby and colleagues are exploring the factors that contribute to antibody production and quality, which are key to our defense against pathogens and response to vaccines.

Health collaborative helps rural hospitals curb operating costs

Alomere Health, a 99-bed hospital in rural Alexandria, Minnesota, is bucking a trend — thanks in large measure to its participation in the Vanderbilt Health Purchasing Collaborative (VHPC), a wholly-owned subsidiary of Vanderbilt University Medical Center.

Directorships honor leaders, philanthropic partners

On April 16, Vanderbilt University Medical Center held its second Directorship Celebration to honor 10 leaders from across the enterprise in clinical care, research, education and administration.

1 2